AQIA (Aquiva Group) 3-1 Month Momentum %: 11.11% (As of Sep. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aquiva Group 3-1 Month Momentum %?

Aquiva Group AQIA 3-1 Month Momentum % is 11.11% as of Sep. 03, 2026.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-03), Aquiva Group's 3-1 Month Momentum % is 11.11%.

The industry rank for Aquiva Group's 3-1 Month Momentum % or its related term are showing as below:

AQIA's 3-1 Month Momentum % is not ranked
in the Software industry.
Industry Median: -5.75 vs AQIA: 11.11

Aquiva Group  (OTCPK:AQIA) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Aquiva Group 3-1 Month Momentum % Related Terms

AQIA vs LOGQ, MUSS, KLMN: 3-1 Month Momentum % Comparison

For the Software - Application subindustry, Aquiva Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquiva Group 3-1 Month Momentum % vs Software Industry

For the Software industry and Technology sector, Aquiva Group's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Aquiva Group's 3-1 Month Momentum % falls into.


Aquiva Group  (OTCPK:AQIA) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 11.11% mean?
Aquiva Group (AQIA) has a 3-1 Month Momentum % of 11.11% as of Sep. 03, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Aquiva Group and its competitors.
Is Aquiva Group's 3-1 Month Momentum % too high?
Aquiva Group's current 3-1 Month Momentum % is 11.11%.
How does Aquiva Group's 3-1 Month Momentum % compare to LOGQ and MUSS?
Aquiva Group's 3-1 Month Momentum % of 11.11% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Software company?
A good 3-1 Month Momentum % depends on the Software industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Aquiva Group and its competitors. Aquiva Group's current 3-1 Month Momentum % is 11.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquiva Group stock overvalued right now?
Aquiva Group (AQIA) has a current 3-1 Month Momentum % of 11.11%. The current 3-1 Month Momentum % is 11.11%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Aquiva Group (AQIA), the current 3-1 Month Momentum % is 11.11% as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquiva Group Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
Aquiva Group Inc is focused on commercializing materials science technologies in both existing and emerging markets. It has licensed a novel HiPNATM (Hydrogel with InterPenetrating Network Anchor) technology, branded as AquiFormTM, which is a versatile material with key properties, making it an attractive platform for various applications. These applications include transdermal patches that release active ingredients for skin care, nutraceuticals, and other healthcare and cosmetics markets. The company operates across three segments: Consumer Health, Wellness, & Cosmetics; Medical Device; and Therapeutics & Transdermal Drug-Delivery Systems (TDS). Additionally, it is building on an established partnership network and capabilities in contract development to expand its services to new areas.